Impotence Clinical Trials

A listing of Impotence medical research trials actively recruiting patient volunteers. Search for closest city to find more detailed information on a research study in your area.

Filter By
Clear all Advanced
I am/have/had
added new label for I am/have/had
more
I am looking for
added new label for I am looking for
more
Advanced Filters
Found 166 clinical trials
None

  • None views
None

  • None views
None

  • None views
None

  • None views
Patients With ES-SCLC and ECOG PS=2 Receiving Atezolizumab-Carboplatin-Etoposide

The combination of cis- or carboplatin and etoposide is the standard of care in the first-line treatment of stage IV (extensive-disease) SCLC (ED-SCLC). Despite response rates of 50-80%, most patients relapse within six months and the median survival time is less than 10 months.

corticosteroid therapy
carboplatin
liver metastasis
atezolizumab
neuroendocrine tumor
  • 0 views
  • 19 Feb, 2024
  • 1 location
Efficacy of Hydroxychloroquine Prophylaxis for Health Care Workers at High Risk for COVID-19

The HCW Prophylaxis (HCWP) Study, single, open and off label intervention study. Up to 350 participants will be assigned to group that takes HCQ or group that opts to not take study medication. Participants will be UNM HEALTH SYSTEM HCW at high risk for occupational exposure to SARSCoV- 2. Study …

occupational exposure
covid-19
acute respiratory syndrome (sars)
pediatric
hydroxychloroquine
  • 0 views
  • 19 Feb, 2024
  • 1 location